BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 25, 2003
View Archived Issues
CX-659S prevents rebound after prednisolone treatment
Read More
Effective use of sumatriptan in OCD
Read More
Good efficacy and safety profile established for atlizumab in rheumatoid arthritis
Read More
Antitumor effects described for SU-11654 in spontaneous canine tumors
Read More
Potential of levetiracetam in neuropathic pain
Read More
Genta acquires license to siRNA
Read More
Long-term efficacy of Retaane demonstrated in 24-month wet AMD trial
Read More
Fougera's lidocaine/prilocaine cream approved by FDA
Read More
NicOx and Merck sign research evaluation agreement for nitric oxide-donating drugs
Read More
IND filed for Atrigel formulation of octreotide
Read More
Fast track designation awarded to ABthrax
Read More
Merck & Co. discontinues development of first Karo Bio collaboration compound
Read More
Phase I bridging study of LEP-ETU commences
Read More
Levitra receives FDA approval
Read More
Thalidomide recommended for approval in Australia
Read More
Priority review for Vitrase NDA
Read More
Janssen patent covers prucalopride N-oxide isomers and their use
Read More
New acetylcholine receptor modulators in early development at Merck KGaA
Read More
Axovan scientists present novel antiobesity NPY Y5 antagonists
Read More
New PARP inhibitors and their use in ischemia-reperfusion injury
Read More
New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer
Read More